Zhangya Pu

792 total citations · 1 hit paper
23 papers, 506 citations indexed

About

Zhangya Pu is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Zhangya Pu has authored 23 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Zhangya Pu's work include Antimicrobial Resistance in Staphylococcus (7 papers), Ferroptosis and cancer prognosis (5 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Zhangya Pu is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Ferroptosis and cancer prognosis (5 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Zhangya Pu collaborates with scholars based in China and United States. Zhangya Pu's co-authors include Jinxin Zheng, Qiwen Deng, Dan G. Duda, Zhijian Yu, Duoyun Li, Lingling Zhu, Weiming Yao, Zhiping Ruan, Zhiwei Lin and Yuling Xiao and has published in prestigious journals such as Nature Communications, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.

In The Last Decade

Zhangya Pu

22 papers receiving 498 citations

Hit Papers

Combining p53 mRNA nanotherapy with immune checkpoint blo... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy
    2022 179 citations Yuling Xiao, Hui Zhou et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhangya Pu China 11 260 144 91 83 77 23 506
Kelsi Penewit United States 14 289 1.1× 155 1.1× 43 0.5× 62 0.7× 40 0.5× 32 621
Percy Schröttner Germany 13 207 0.8× 62 0.4× 159 1.7× 78 0.9× 70 0.9× 37 583
Renjie Zhou China 13 295 1.1× 141 1.0× 47 0.5× 44 0.5× 40 0.5× 25 465
Raj Kumar Verma India 16 258 1.0× 93 0.6× 131 1.4× 45 0.5× 116 1.5× 36 731
Huaijie Hao China 17 246 0.9× 141 1.0× 83 0.9× 53 0.6× 171 2.2× 33 650
Go Kamoshida Japan 16 234 0.9× 194 1.3× 227 2.5× 27 0.3× 67 0.9× 33 662
Robert D. Schrock United States 11 545 2.1× 112 0.8× 70 0.8× 66 0.8× 136 1.8× 16 1.0k
Abiye Tigabu Ethiopia 11 79 0.3× 79 0.5× 60 0.7× 39 0.5× 95 1.2× 23 387
Udo Lorenz Germany 15 252 1.0× 198 1.4× 85 0.9× 35 0.4× 46 0.6× 26 570
Zachary Cusumano United States 13 349 1.3× 94 0.7× 93 1.0× 21 0.3× 68 0.9× 21 782

Countries citing papers authored by Zhangya Pu

Since Specialization
Citations

This map shows the geographic impact of Zhangya Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhangya Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhangya Pu more than expected).

Fields of papers citing papers by Zhangya Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhangya Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhangya Pu. The network helps show where Zhangya Pu may publish in the future.

Co-authorship network of co-authors of Zhangya Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhangya Pu. A scholar is included among the top collaborators of Zhangya Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhangya Pu. Zhangya Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaofang, Zhangya Pu, Yixiang Zheng, et al.. (2024). Development and validation of a novel prognostic nomogram for hepatitis B virus-related acute-on-chronic liver failure patients receiving artificial liver therapy. European journal of medical research. 29(1). 556–556.
2.
Zhao, Shuai, Qiuhong Liu, Fen Zhang, et al.. (2024). Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance. BMC Infectious Diseases. 24(1). 567–567. 1 indexed citations
3.
Pu, Zhangya, et al.. (2024). Cellular Senescence in Acute Liver Injury: What Happens to the Young Liver?. Aging and Disease. 16(3). 0–0. 3 indexed citations
4.
Zhu, Yuanyuan, Zhangya Pu, Ying Ni Lin, et al.. (2022). Pancancer Analysis of the Prognostic and Immunotherapeutic Value of Progestin and AdipoQ Receptor 4. Computational and Mathematical Methods in Medicine. 2022. 1–24. 1 indexed citations
5.
Pu, Zhangya, Jinghua Liu, Zelong Liu, et al.. (2022). STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment. Cancer Cell International. 22(1). 314–314. 10 indexed citations
6.
Xiao, Yuling, Hui Zhou, Xiaodong Zeng, et al.. (2022). Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy. Nature Communications. 13(1). 758–758. 179 indexed citations breakdown →
7.
Pu, Zhangya, Chen Jiang, Peng Fang, et al.. (2022). Establishment and validation of prognostic nomograms to predict the overall and cancer-specific survival in patients with hepatic malignant vascular tumors.. PubMed. 14(2). 798–818. 1 indexed citations
8.
9.
Pu, Zhangya, Dan G. Duda, Yuanyuan Zhu, et al.. (2022). VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway. Journal of Translational Medicine. 20(1). 212–212. 33 indexed citations
10.
Zhu, Yuanyuan, et al.. (2021). Soluble resistance-related calcium-binding protein participates in multiple diseases via protein-protein interactions. Biochimie. 189. 76–86. 6 indexed citations
11.
Zhu, Yuanyuan, Zhangya Pu, Guoqiang Wang, et al.. (2021). FAM3C : An Emerging Biomarker and Potential Therapeutic Target for Cancer. Biomarkers in Medicine. 15(5). 373–384. 18 indexed citations
12.
Zhu, Yuanyuan, et al.. (2021). Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma. Frontiers in Oncology. 11. 700528–700528. 16 indexed citations
13.
Pu, Zhangya, Yuanyuan Zhu, Xiaofang Wang, et al.. (2021). Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network. Frontiers in Genetics. 12. 591623–591623. 6 indexed citations
14.
Wen, Zewen, Yongpeng Shang, Guangjian Xu, et al.. (2020). Mechanism of Eravacycline Resistance in Clinical Enterococcus faecalis Isolates From China. Frontiers in Microbiology. 11. 916–916. 20 indexed citations
15.
Yao, Weiming, Duoyun Li, Zhangya Pu, et al.. (2019). Linezolid Consumption Facilitates the Development of Linezolid Resistance in Enterococcus faecalis in a Tertiary-Care Hospital: A 5-Year Surveillance Study. Microbial Drug Resistance. 25(6). 791–798. 17 indexed citations
16.
17.
Zheng, Jinxin, Yang Wu, Zhiwei Lin, et al.. (2017). Characteristics of and Virulence Factors Associated with Biofilm Formation in Clinical Enterococcus faecalis Isolates in China. Frontiers in Microbiology. 8. 2338–2338. 62 indexed citations
18.
Zheng, Jinxin, Hui Li, Zhangya Pu, et al.. (2017). Bloodstream infections caused by Enterococcus spp: A 10-year retrospective analysis at a tertiary hospital in China. Journal of Huazhong University of Science and Technology [Medical Sciences]. 37(2). 257–263. 10 indexed citations
19.
H, Su, Zhongjun Shao, Zhangya Pu, et al.. (2017). Overt and occult hepatitis B virus infection among community children in Northwest China. Journal of Viral Hepatitis. 24(9). 797–803. 10 indexed citations
20.
Zheng, Jinxin, Bing Bai, Zhiwei Lin, et al.. (2017). Characterization of biofilm formation by Enterococcus faecalis isolates derived from urinary tract infections in China. Journal of Medical Microbiology. 67(1). 60–67. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelsi Penewit Breakdown of academic impact, for papers by Percy Schröttner Breakdown of academic impact, for papers by Renjie Zhou Breakdown of academic impact, for papers by Raj Kumar Verma Breakdown of academic impact, for papers by Huaijie Hao Breakdown of academic impact, for papers by Go Kamoshida Breakdown of academic impact, for papers by Robert D. Schrock Breakdown of academic impact, for papers by Abiye Tigabu Breakdown of academic impact, for papers by Udo Lorenz Breakdown of academic impact, for papers by Zachary Cusumano
Rankless by CCL
2026